Department of Pharmaceutical Sciences, University of California San Francisco Medical Center, 505 Parnassus Ave, San Francisco, CA, 94143, USA.
Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, 513 Parnassus Ave, San Francisco, CA, 94143, USA.
Obes Surg. 2022 Aug;32(8):2618-2624. doi: 10.1007/s11695-022-06022-y. Epub 2022 Mar 29.
To evaluate the impact of a bariatric clinic-based pharmacist on inpatient length of stay, medication errors, and patient experience.
This was a retrospective cohort study comparing patients who received a pre-operative pharmacist consultation to historical cases without pre-operative pharmacist consultation prior to admission for bariatric surgery. A patient experience survey was administered post-operatively to the intervention group. The primary outcome was hospital length of stay (LOS). Secondary outcomes included corrected medication errors on reconciliation, pharmacist interventions, adverse drug event (ADE) prevention, and patient satisfaction.
With 68 patients in the intervention group and 67 patients in the control group, the majority were female (76%) and received either laparoscopic Roux-en-Y gastric bypass (53%) or sleeve gastrectomy (47%). The median LOS in the intervention group was 55.5 h, which did not significantly differ from the median 57.9 h in the control group (p = 0.56). The clinic-based pharmacist made an average of 13 interventions per patient. Surveys were distributed to 73 patients with a 60% response rate. High overall satisfaction with the pre-operative pharmacist consultation was reported by 97% of patients.
Although hospital LOS did not significantly differ between groups, pre-operative pharmacist consultation prevented potential ADEs, and provided strong patient satisfaction. Having pharmacists as part of a multidisciplinary approach to bariatric surgery patient care can prevent medication-related adverse events and improve patient satisfaction.
评估基于减重诊所的药剂师对住院患者住院时间、用药错误和患者体验的影响。
这是一项回顾性队列研究,比较了接受术前药剂师咨询的患者与接受减重手术入院前无术前药剂师咨询的历史病例。术后向干预组患者发放患者体验调查。主要结果是住院时间(LOS)。次要结果包括在药物重整时纠正的用药错误、药剂师干预、药物不良事件(ADE)预防和患者满意度。
干预组有 68 例患者,对照组有 67 例患者,大多数为女性(76%),接受腹腔镜 Roux-en-Y 胃旁路术(53%)或袖状胃切除术(47%)。干预组的中位 LOS 为 55.5 小时,与对照组的中位 LOS(57.9 小时)无显著差异(p=0.56)。诊所的药剂师平均为每位患者进行 13 次干预。向 73 名患者发放了调查问卷,回复率为 60%。97%的患者对术前药剂师咨询总体满意度较高。
尽管两组患者的住院时间无显著差异,但术前药剂师咨询可预防潜在的 ADE,并提供较高的患者满意度。让药剂师成为减重手术患者护理多学科方法的一部分,可以预防与药物相关的不良事件并提高患者满意度。